---
document_datetime: 2024-09-06 11:24:46
document_pages: 16
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/savene-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: savene-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 8.5293636
conversion_datetime: 2025-12-27 21:16:46.883926
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Savene

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                     | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary                           |
|----------------------|-----------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------------------------------|
| T/0052               | Transfer of Marketing Authorisation                       | 23/07/2024                          | 22/08/2024                                  | SmPC, Labelling and PL           |                                   |
| PSUSA/1001/ 202302   | Periodic Safety Update EU Single assessment - dexrazoxane | 28/09/2023                          | n/a                                         |                                  | PRAC Recommendation - maintenance |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| IB/0050            | B.II.b.5.f - Change to in-process tests or limits applied during the manufacture of the finished product - Addition or replacement of an in-process test as a result of a safety or quality issue                                                                                                                                                                                                                                                                                                                                       | 12/07/2023   | n/a   |                                   |
|--------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|-----------------------------------|
| PSUSA/1001/ 202202 | Periodic Safety Update EU Single assessment - dexrazoxane                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 29/09/2022   | n/a   | PRAC Recommendation - maintenance |
| IA/0048            | B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits                                                                                                                                                                                                                                                                                                                                                                                  | 12/07/2022   | n/a   |                                   |
| IB/0046/G          | This was an application for a group of variations. B.I.a.2.e - Changes in the manufacturing process of the AS - Minor change to the restricted part of an ASMF A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient B.I.a.4.a - Change to in-process tests or limits applied during the manufacture of the AS - Tightening of in-process limits | 20/04/2022   | n/a   |                                   |
| PSUSA/1001/ 202102 | Periodic Safety Update EU Single assessment - dexrazoxane                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 30/09/2021   | n/a   | PRAC Recommendation - maintenance |
| IA/0045/G          | This was an application for a group of variations.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | 18/06/2021   | n/a   |                                   |

<div style=\"page-break-after: always\"></div>

|                    | B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure                                                                                                                                                                                                                                          |            |     |                                   |
|--------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-----------------------------------|
| IB/0043/G          | This was an application for a group of variations. B.I.z - Quality change - Active substance - Other variation B.I.b.1.d - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter) B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits | 15/01/2021 | n/a |                                   |
| PSUSA/1001/ 202002 | Periodic Safety Update EU Single assessment - dexrazoxane                                                                                                                                                                                                                                                                                                                                                                                                                                 | 01/10/2020 | n/a | PRAC Recommendation - maintenance |
| IB/0041            | B.II.b.5.z - Change to in-process tests or limits applied during the manufacture of the finished product - Other variation                                                                                                                                                                                                                                                                                                                                                                | 08/04/2020 | n/a |                                   |
| PSUSA/1001/ 201902 | Periodic Safety Update EU Single assessment - dexrazoxane                                                                                                                                                                                                                                                                                                                                                                                                                                 | 03/10/2019 | n/a | PRAC Recommendation - maintenance |

<div style=\"page-break-after: always\"></div>

| IA/0039/G          | This was an application for a group of variations. A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or   | 18/03/2019   | n/a        |                           |                                   |
|--------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|---------------------------|-----------------------------------|
| T/0038             | Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                                                                                                                                                                        | 21/11/2018   | 11/01/2019 | SmPC, Labelling and PL    |                                   |
| PSUSA/1001/ 201802 | Periodic Safety Update EU Single assessment - dexrazoxane                                                                                                                                                                                                                                                                                                                                                                                                  | 04/10/2018   | n/a        |                           | PRAC Recommendation - maintenance |
| II/0036            | C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data                                                                                                                                                                                                                                                                                                                                          | 26/07/2018   | 11/01/2019 | SmPC, Labelling and PL    |                                   |
| IA/0035            | B.II.e.1.b.3 - Change in immediate packaging of the finished product - Change in type/addition of a new container - Deletion of an immediate packaging container without a complete deletion of a strength or pharmaceutical form                                                                                                                                                                                                                          | 08/02/2018   | 11/01/2019 | SmPC and Annex II         |                                   |
| II/0034/G          | This was an application for a group of variations.                                                                                                                                                                                                                                                                                                                                                                                                         | 12/10/2017   | 15/11/2017 | SmPC, Annex II, Labelling |                                   |

<div style=\"page-break-after: always\"></div>

|                    | C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data                                                                                                                    |            |     | and PL   |                                   |
|--------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|----------|-----------------------------------|
| PSUSA/1001/ 201702 | Periodic Safety Update EU Single assessment - dexrazoxane                                                                                                                                                                                                                                                                                                                                                                                                                | 26/10/2017 | n/a |          | PRAC Recommendation - maintenance |
| II/0031            | B.I.b.z - Change in control of the AS - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                  | 08/12/2016 | n/a |          |                                   |
| IA/0032/G          | This was an application for a group of variations. B.I.a.1.f - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for the AS -replacement or addition of a site where batch control/testing takes place B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place | 17/10/2016 | n/a |          |                                   |
| IA/0030/G          | This was an application for a group of variations. B.II.e.2.b - Change in the specification parameters and/or limits of the immediate packaging of the                                                                                                                                                                                                                                                                                                                   | 20/04/2016 | n/a |          |                                   |

<div style=\"page-break-after: always\"></div>

|           | finished product - Addition of a new specification parameter to the specification with its corresponding test method B.II.e.6.b - Change in any part of the (primary) packaging material not in contact with the finished product formulation - Change that does not affect the product information                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |            |     |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| IB/0029   | B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | 14/04/2016 | n/a |
| IB/0027/G | This was an application for a group of variations. B.II.d.1.a - Change in the specification parameters and/or limits of the finished product - Tightening of specification limits B.II.d.1.c - Change in the specification parameters and/or limits of the finished product - Addition of a new specification parameter to the specification with its corresponding test method B.II.d.1.c - Change in the specification parameters and/or limits of the finished product - Addition of a new specification parameter to the specification with its corresponding test method B.II.d.1.c - Change in the specification parameters and/or limits of the finished product - Addition of a new specification parameter to the specification with its corresponding test method B.II.d.1.c - Change in the specification parameters and/or limits of the finished product - Addition of a | 09/12/2015 | n/a |

<div style=\"page-break-after: always\"></div>

| its corresponding test method B.II.d.1.c - Change in and/or limits of the finished new specification parameter its corresponding test method B.II.d.1.c - Change in and/or limits of the finished new specification parameter its corresponding test method B.II.d.1.c - Change in and/or limits of the finished new specification parameter its corresponding test method B.II.d.1.c - Change in and/or limits of the finished new specification parameter its corresponding test method B.II.d.1.c - Change in and/or limits of the finished new specification parameter its corresponding test method B.II.d.1.c - Change in and/or limits of the finished new specification parameter its corresponding test method B.II.d.1.c - Change in and/or limits of the finished new specification parameter its corresponding test method B.II.d.1.d - Change in and/or limits of the finished   |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

|           | Change in the specification parameters and/or limits of the finished product - Deletion of a non-significant specification parameter B.II.d.1.d - Change in the specification parameters and/or limits of the finished product - Deletion of a non-significant specification parameter B.II.d.1.i - Change in the specification parameters and/or limits of the finished product - Ph. Eur. 2.9.40 uniformity of dosage units is introduced to replace the currently registered method, either Ph. Eur. 2.9.5 or Ph. Eur. 2.9.6 B.II.d.1.z - Change in the specification parameters and/or limits of the finished product - Other variation B.II.d.1.z - Change in the specification parameters and/or limits of the finished product - Other variation   |            |     | B.II.d.1.d -   |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|----------------|
| II/0025   | B.I.z - Quality change - Active substance - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 29/10/2015 | n/a |                |
| IB/0028/G | This was an application for a group of variations. B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure                                                                                                                                                                                                                                                              | 16/10/2015 | n/a |                |

<div style=\"page-break-after: always\"></div>

|           | or addition) B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition) B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure   |            |     | (including replacement   |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|--------------------------|
| IA/0026/G | This was an application for a group of variations. B.I.a.1.f - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for the AS -replacement or addition of a site where batch control/testing takes place B.I.a.1.f - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for the AS -replacement or addition of a site where control/testing takes place                                                                        | 21/08/2015 | n/a | batch                    |
| IAIN/0024 | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | 01/07/2015 | n/a |                          |

<div style=\"page-break-after: always\"></div>

|             | contact details) and/or changes in the location                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |            |            |                 | (including PSMF   |
|-------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-----------------|-------------------|
| IAIN/0023/G | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites A.7 - Administrative change - Deletion of manufacturing sites A.7 - Administrative change - Deletion of manufacturing sites A.7 - Administrative change - Deletion of manufacturing sites A.7 - Administrative change - Deletion of manufacturing sites B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place | 30/04/2015 | 11/03/2016 | Annex II and PL |                   |

<div style=\"page-break-after: always\"></div>

|                    | manufacturing site for the FP - Secondary packaging site A.7 - Administrative change - Deletion of manufacturing sites B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing   |            |            |                                  |                                                                                                                                                            |
|--------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0022            | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                  | 26/03/2015 | 11/03/2016 | SmPC, Annex II, Labelling and PL |                                                                                                                                                            |
| PSUSA/1001/ 201402 | Periodic Safety Update EU Single assessment - dexrazoxane                                                                                                                                                                                                                                                                                                       | 23/10/2014 | 12/01/2015 | SmPC and PL                      | Please refer to dexrazoxane - PSUSA 10001 EPAR: Scientific conclusions and grounds recommending the variation of the terms of the marketing authorisation. |
| IAIN/0021          | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location                                                                                                                                                                                                 | 28/11/2014 | n/a        |                                  |                                                                                                                                                            |
| IAIN/0020          | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location                                                                                                                                                                                                 | 10/10/2014 | n/a        |                                  |                                                                                                                                                            |
| IAIN/0019          | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location                                                                                                                                                                                                 | 06/08/2014 | n/a        |                                  |                                                                                                                                                            |

<div style=\"page-break-after: always\"></div>

| T/0017      | Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | 16/06/2014   | 18/07/2014   | SmPC, Labelling and PL   |                             |
|-------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|--------------------------|-----------------------------|
| IAIN/0016/G | This was an application for a group of variations. B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release) A.7 - Administrative change - Deletion of manufacturing sites B.II.b.1.a - Replacement or addition of a the FP - Secondary packaging | 30/04/2014   | 18/07/2014   | Annex II and PL          | manufacturing site for site |
| T/0014      | Transfer of Marketing Authorisation from SpePharm Holding BV to Norgine BV. Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 01/08/2013   | 19/09/2013   | SmPC, Labelling and PL   |                             |
| N/0015      | Inclusion of Croatian Product information and Croatian local representative in Annex IIIB. Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                     | 27/08/2013   | n/a          |                          |                             |

<div style=\"page-break-after: always\"></div>

<!-- image -->

| II/0013/G   | This was an application for a group of                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | 21/06/2012   | 20/07/2012   | SmPC, Labelling and   |
|-------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|-----------------------|
|             | variations. -to change the immediate packaging for the Savene diluent from 500 ml PE bags to 500 ml glass bottles -to change the manufacturer of Savene diluent, the suppliers of the packaging components for the diluent and the site responsible for Savene diluent batch control -to change the specifications and composition of Savene diluent and to introduce changes to analytical methods used in the control of the same and -to modify the reconstitution procedure for Savene powder. B.II.b.1.z - Replacement or addition of a manufacturing site for the FP - Other variation B.II.d.1.a - Change in the specification parameters and/or limits of the finished product - Tightening of specification limits B.II.e.7.b - Change in supplier of packaging components or devices (when mentioned in the dossier) - Replacement or addition of a supplier B.II.b.2.a - Change to batch release arrangements and quality control testing of the FP - Replacement or addition of a site where batch control/testing takes place |              |              | PL                    |

<div style=\"page-break-after: always\"></div>

|           | product - Other changes to a test procedure (including replacement or addition) B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition) B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition) C.I.4 - Variations related to significant modifications of the SPC due in particular to new quality, pre- clinical, clinical or pharmacovigilance data B.II.e.1.b.2 - Change in immediate packaging of the finished product - Type of container - Sterile medicinal products and biological/immunological medicinal products B.II.d.1.e - Change in the specification parameters and/or limits of the finished product - Change outside the approved specifications limits range   |            |            |                                  |                                                                                                                                                                                                                                                                                                                                                                                                               |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| R/0012    | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | 19/05/2011 | 18/07/2011 | SmPC, Annex II, Labelling and PL | Based on the review of the available information the CHMP is of the opinion that the quality, the safety and the efficacy of Savene continues to be adequately and sufficiently demonstrated and considers that the benefit/risk profile of this medicinal product continues to be favourable. The CHMP therefore recommended that the Savene Marketing Authorisation can be renewed with unlimited validity. |
| IA/0010/G | This was an application for a group of variations. B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | 16/02/2011 | n/a        |                                  |                                                                                                                                                                                                                                                                                                                                                                                                               |

<div style=\"page-break-after: always\"></div>

|         | Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for the AS -replacement or addition of a site where batch control/testing takes place A.5.b - Administrative change - Change in the name and/or address of a manufacturer of the finished product, including quality control sites (excluding manufacturer for batch release) A.7 - Administrative change - Deletion of manufacturing sites B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.2.a - Change to batch release arrangements and quality control testing of the FP - Replacement or addition of a site where batch control/testing   |            |            |                                  | B.I.a.1.f - takes place   |
|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|---------------------------|
| N/0009  | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | 23/09/2010 | n/a        | PL                               |                           |
| T/0007  | Transfer of Marketing Authorisation from TopoTarget A/S to SpePharm Holding BV. Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 02/06/2010 | 06/07/2010 | SmPC, Annex II, Labelling and PL |                           |
| IA/0008 | B.II.b.2.b.1 - Change to batch release arrangements and quality control testing of the FP - Not including batch control/testing                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | 25/05/2010 | n/a        | Annex II and PL                  |                           |

<div style=\"page-break-after: always\"></div>

| IA/0006   | IA_38_a_Change in test procedure of finished product - minor change to approved test procedure   | 24/06/2008   | n/a   |                 |
|-----------|--------------------------------------------------------------------------------------------------|--------------|-------|-----------------|
| IA/0005   | IA_28_Change in any part of primary packaging material not in contact with finished product      | 13/05/2008   | n/a   |                 |
| N/0004    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification) | 11/02/2008   | n/a   | PL              |
| N/0003    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification) | 28/08/2007   | n/a   | PL              |
| N/0002    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification) | 04/04/2007   | n/a   | PL              |
| IA/0001   | IA_08_b_01_Change in BR/QC testing - repl./add. manuf. responsible for BR - not incl. BC/testing | 14/08/2006   | n/a   | Annex II and PL |